|
KIAA1211 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.096400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.031130E-04 |
| Normal-vs-Stage2 |
8.472000E-01 |
| Normal-vs-Stage3 |
4.862800E-01 |
| Normal-vs-Stage4 |
4.387600E-01 |
| Stage1-vs-Stage2 |
3.037200E-01 |
| Stage1-vs-Stage3 |
3.608100E-02 |
| Stage1-vs-Stage4 |
9.941600E-02 |
| Stage2-vs-Stage3 |
5.301600E-01 |
| Stage2-vs-Stage4 |
4.590200E-01 |
| Stage3-vs-Stage4 |
7.960200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.690000E-02 |
| Normal-vs-AfricanAmerican |
2.506000E-02 |
| Normal-vs-Asian |
5.234000E-01 |
| Caucasian-vs-AfricanAmerican |
3.123400E-01 |
| Caucasian-vs-Asian |
8.963800E-01 |
| AfricanAmerican-vs-Asian |
6.127400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.797650E-04 |
| Normal-vs-Female |
3.135200E-01 |
| Male-vs-Female |
2.463700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.755200E-01 |
| Normal-vs-Extreme_Weight |
1.121250E-03 |
| Normal-vs-Obese |
5.777000E-01 |
| Normal-vs-Extreme_Obese |
8.14459999998185E-07 |
| Normal_Weight-vs-Extreme_Weight |
6.976000E-02 |
| Normal_Weight-vs-Obese |
7.060200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.780300E-03 |
| Extreme_Weight-vs-Obese |
9.421900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.542500E-02 |
| Obese-vs-Extreme_Obese |
4.901200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.769390E-01 |
| Normal-vs-Age(41-60Yrs) |
2.292200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.814790E-04 |
| Normal-vs-Age(81-100Yrs) |
8.784000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.149160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.392000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.485900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.580100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.417800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.712400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.88930000000398E-05 |
| Normal-VS-Type2 PRCC |
6.240600E-01 |
| Normal-VS-KIRP CIMP |
2.284200E-02 |
| Normal-VS-Unclassified PRCC |
2.937200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.638200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.078100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.757800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.023800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.595200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.701900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.354800E-01 |
| Normal-vs-N1 |
9.191800E-02 |
| Normal-vs-N2 |
1.321970E-01 |
| N0-vs-N1 |
5.284200E-02 |
| N0-vs-N2 |
1.182820E-01 |
| N1-vs-N2 |
1.181960E-01 |
|
|
